Ellevest’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Ellevest's DGX Position: Q3 2026 in Review
Ellevest increased its Quest Diagnostics (DGX) stake by 4.8% in Q3 2026, buying an estimated $13.6K and bringing the position to 1,276 shares worth $297K. The position accounts for 0.03% of the portfolio, ranked #342.
Ellevest first reported a position in DGX in Q3 2019 and has held it in 12 quarters since. 978 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Ellevest held 1,276 shares of Quest Diagnostics worth $297K as of Q3 2026.
- Ellevest bought 59 Quest Diagnostics shares in Q3 2026, an estimated $13.6K.
- Quest Diagnostics made up 0.03% of Ellevest's portfolio in Q3 2026, its #342 holding.
- Ellevest first reported a position in Quest Diagnostics in Q3 2019 and has held it in 12 quarters since.
- 978 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Ellevest's 13F filing for Q3 2026, filed 10 Nov 2026.